| Stage | BRK-B | % of rev | HIPO | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $102B | 100.00% | $156M | 100.00% | BRK-B ×652.62 |
| Gross profit | $55.9B | 54.87% | $44M | 28.21% | BRK-B +26.7pp |
| Operating income | $17.1B | 16.77% | $9M | 5.71% | BRK-B +11.1pp |
| Pre-tax income | $31.8B | 31.25% | $9M | 5.71% | BRK-B +25.5pp |
| Net income | $25.8B | 25.31% | $9M | 5.64% | BRK-B +19.7pp |
| Stage | BRK-B | HIPO | Gap · A − B |
|---|---|---|---|
| Revenue | $102B100.00% | $156M100.00% | BRK-B ×652.62 |
| Gross profit | 54.87%$55.9B | 28.21%$44M | BRK-B +26.7pp |
| Operating income | 16.77%$17.1B | 5.71%$9M | BRK-B +11.1pp |
| Pre-tax income | 31.25%$31.8B | 5.71%$9M | BRK-B +25.5pp |
| Net income |
| 25.31%$25.8B |
| 5.64%$9M |
| BRK-B +19.7pp |
No disclosed counterparties: BRK-B, HIPO.